Cargando…
Levo-α-acetylmethadol (LAAM) induced QTc-prolongation - results from a controlled clinical trial
BACKGROUND: Due to potential proarrhythmic side-effects levo-α-Acetylmethadol (LAAM) is currently not available in EU countries as maintenance drug in the treatment of opiate addiction. However, recent studies and meta-analyses underline the clinical advantages of LAAM with respect to the reduction...
| Autores principales: | , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2009
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3352205/ https://www.ncbi.nlm.nih.gov/pubmed/19258204 http://dx.doi.org/10.1186/2047-783X-14-1-7 |